The Role Of Attention In Modifying Neural Plasticity In The Adult Human Cortex
Funder
National Health and Medical Research Council
Funding Amount
$391,242.00
Summary
The human brain is constantly changing in response to experience. These changes, known as plasticity, are necessary to respond to new environments, to learn new skills and to recover from brain injury. This project will determine how selective attention, a process that filters sensory information in the brain, alters brain plasticity. The outcomes will inform the design of rehabilitation treatments for individuals with a brain injury.
Chronic pain is a common and debilitating condition. One in five people in the Australian community have been found to experience chronic pain at any one time. Although there is no evidence of a consistent increase in rates of chronic pain, the rate of permanent disability has increased dramatically in recent decades. This has contributed to the growing cost of chronic pain. For example, back pain is the most common reason for filing workers' compensation claims and leads to loss of 101.8 millio ....Chronic pain is a common and debilitating condition. One in five people in the Australian community have been found to experience chronic pain at any one time. Although there is no evidence of a consistent increase in rates of chronic pain, the rate of permanent disability has increased dramatically in recent decades. This has contributed to the growing cost of chronic pain. For example, back pain is the most common reason for filing workers' compensation claims and leads to loss of 101.8 million workdays annually. The annual costs of medical care for back pain alone have been estimated at $AUD50 billion in the US and $10 billion in Australia. Not only is chronic pain a considerable economic burden, it is also a considerable personal burden to patients. Pain is one of the strongest predictors of poor quality of life and has consistently been found to be associated with high rates of depression. Although there is a large body of research that investigates what factors are associated with chronic pain, there is surprisingly little research that investigates the mechanisms that cause chronicity. Theories of chronic pain suggest that psychological characteristics increase the propensity for people to develop chronic pain. Specifically, theories argue that those people who tend to be fearful of pain will over-attend to painful sensations and avoid pain-provoking activities and as a result are at risk of developing chronic pain. This study will test those theories. If it is found that over-attending to pain does predispose patients to develop chronic pain, this will have important implications for preventing the development of chronic pain. These findings could help to devise early interventions to prevent chronicity and thereby reduce the economic burden to health services and the emotional burden to patients in terms of reduced quality of life.Read moreRead less
Neuroanatomical Dynamics Of Attention In Stroke Patients And Healthy Individuals: A Magnetic Stimulation Investigation
Funder
National Health and Medical Research Council
Funding Amount
$360,363.00
Summary
Mechanisms of selective attention are of central importance in guiding human behaviour. The brain uses attention to enhance the processing of information that is behaviourally relevant, and to suppress irrelevant information. The operation of attention within sensory modalities (vision, touch, hearing) has been studied for many decades; however, little is known about how attention combines information between different senses. An understanding of 'crossmodal' attention is important for many reas ....Mechanisms of selective attention are of central importance in guiding human behaviour. The brain uses attention to enhance the processing of information that is behaviourally relevant, and to suppress irrelevant information. The operation of attention within sensory modalities (vision, touch, hearing) has been studied for many decades; however, little is known about how attention combines information between different senses. An understanding of 'crossmodal' attention is important for many reasons. First, real events in the environment provide inputs simultaneously from different locations to multiple senses, and these inputs must be integrated to yield coherent perception. Second, the most basic aspects of human perception depend upon attention; the brain implements selective mechanisms in order to filter the immense quantities of information that constantly bombard our sensory receptors. Finally, many neurological disorders are characterised by impairments of attention; these syndromes are debilitating for the patients themselves, and also place a heavy burden on caregivers and the healthcare system. This project will examine mechanisms of attention in healthy individuals and in stroke patients with attentional deficits. In all experiments, we will employ a new technique in neuroscience called 'transcranial magnetic stimulation' (TMS). TMS enables the safe and reversible stimulation of brain activity in humans. In the current project, we will use TMS with two broad objectives: (i) to determine the key brain areas involved in crossmodal attention in healthy individuals, and (ii) to treat attentional deficits that occur within and between the senses in stroke patients ('magnetic stimulation rehabilitation'). This research will provide important insights into the brain mechanisms that govern selective attention in the healthy brain, and will help guide future methods for managing and treating neurological disorders in which deficits of attention are prominent.Read moreRead less
Mechanisms Of Repair And Adaptation In The Gastric Mucosa: Roles Of COX-2 And Growth Factors
Funder
National Health and Medical Research Council
Funding Amount
$391,650.00
Summary
The stomach lining is continually threatened by its own acid and by hazards such as bacteria and ingested drugs. The drugs called COX inhibitors, which include aspirin, are widely used for treating arthritis and other inflammatory diseases and for preventing heart attacks and strokes. Despite their value in these conditions, COX inhibitors are responsible for about 5-10,000 hospital admissions annually in Australia due to complications from the side effect of stomach ulcers. A recent advance has ....The stomach lining is continually threatened by its own acid and by hazards such as bacteria and ingested drugs. The drugs called COX inhibitors, which include aspirin, are widely used for treating arthritis and other inflammatory diseases and for preventing heart attacks and strokes. Despite their value in these conditions, COX inhibitors are responsible for about 5-10,000 hospital admissions annually in Australia due to complications from the side effect of stomach ulcers. A recent advance has been the development of a sub-class called COX-2 inhibitors. In a very short time, one of these has become among the most prescribed drugs in Australia. The advantage of the COX-2 inhibitors is that they produce many less stomach ulcers. However, they have only been tested in patients who have not had a recent history of ulcer. Our preliminary experiments, together with some related information from two overseas groups, suggests that COX-2 is useful in the stomach, and is markedly increased around a healing ulcer. Our data suggest that blocking it delays the healing of experimental ulcers. This project aims to understand the roles of COX-2 in the stomach, and to clarify the effects of inhibiting it when the stomach is damaged or threatened. The project will also look for links between COX-2's functions and another protective process we have discovered called 'adaptation'. When anti-inflammatory drugs are given regularly to rats or humans under certain conditions, the stomach develops resistance after a few days so that the damage caused by each subsequent dose is markedly reduced. We have uncovered a number of mechanisms responsible for this during a current NH and MRC grant, and plan to explore some of the leads this work has given. The SIGNIFICANCE of the project is its potential to lead to safer use of anti-inflammatory drugs or eventually to new agents, and its potential to give new knowledge about how the lining of organs such as the stomach protects itself.Read moreRead less
Antidepressants In Irritable Bowel: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$227,546.00
Summary
Irritable bowel syndrome is a common costly disorder in Australia; one in six Australians suffer with the condition. IBS can cause very substantial disability; some become housebound because of the need to have toilet facilities nearby. The currently available treatments for irritable bowel syndrome only provide at best partial relief or are completely ineffective. The literature suggests that individuals who suffer from an irritable bowel may benefit from the use of an antidepressant medication ....Irritable bowel syndrome is a common costly disorder in Australia; one in six Australians suffer with the condition. IBS can cause very substantial disability; some become housebound because of the need to have toilet facilities nearby. The currently available treatments for irritable bowel syndrome only provide at best partial relief or are completely ineffective. The literature suggests that individuals who suffer from an irritable bowel may benefit from the use of an antidepressant medication. Antidepressant medications have been shown to affect the function of the gastrointestinal system, in addition to relieving some of the psychological symptoms, such as depression and anxiety that are common in individuals with irritable bowel syndrome. To date, there have been no proper controlled trials of antidepressant medications in IBS, and there have been no studies at all into the new class of antidepressant medications, the selective serotonin reuptake inhibitors, in treating IBS. In this study we aim to investigate whether antidepressant medications are effective in treating irritable bowel syndrome by directly comparing a tricyclic (older class of antidepressant) with a selective serotonin reuptake inhibitor (new class of antidepressant) and with a placebo. All study participants will be closely monitored during the study. Patients will have their gastrointestinal symptoms, psychological symptoms, disability, quality of life and tolerance to the medication assessed. This will be the first comprehensive study of antidepressant medications assessed and the irritable bowel syndrome to be undertaken. The study will be conducted at the Nepean Hospital and the Royal North Shore Hospital; both of these centres have a well established treatment and research programs into the irritable bowel syndrome.Read moreRead less
Selective Estrogen Receptor Modulators (SERMs) A Potential Treatment For Psychotic Symptoms Of Schizophrenia?
Funder
National Health and Medical Research Council
Funding Amount
$701,276.00
Summary
Schizophrenia is a serious disease with increasing social and economic costs. We need new treatments to improve the life and functioning of people with schizophrenia. We have published studies showing that estrogen is potentially a new treatment for schizophrenia. New brain estrogens called Selective Estrogen Receptor Modulators have fewer side-effects than standard estrogen. We will conduct a controlled clinical trial of a SERM in 180 postmenopausal women with schizophrenia.